NiQuitin Tropisk Frukt: Uses, Dosage & Side Effects

A tropical fruit flavored nicotine replacement therapy (NRT) chewing gum to help smokers quit by reducing withdrawal symptoms and cravings

OTC ATC: N07BA01 NRT
Active Ingredient
Nicotine (as nicotine polacrilex)
Available Forms
Medicated chewing gum
Strengths
2 mg, 4 mg
Flavor
Tropical Fruit

NiQuitin Tropisk Frukt is a tropical fruit flavored nicotine chewing gum designed to help people stop smoking by providing a controlled, therapeutic dose of nicotine without the harmful chemicals found in tobacco smoke. As a nicotine replacement therapy (NRT), it works by partially satisfying the body's craving for nicotine while the user gradually reduces their dependence. Available in 2 mg and 4 mg strengths, the gum delivers nicotine through the lining of the mouth (buccal mucosa) when chewed using the recommended "chew and park" technique. Nicotine replacement therapy is one of the most extensively studied and evidence-based approaches to smoking cessation, with Cochrane systematic reviews confirming that NRT approximately doubles the chances of successfully quitting compared to willpower alone. NiQuitin Tropisk Frukt is available over the counter without a prescription in most countries.

Quick Facts: NiQuitin Tropisk Frukt

Active Ingredient
Nicotine
Drug Class
NRT
ATC Code
N07BA01
Common Uses
Smoking Cessation
Available Forms
Chewing Gum
Prescription Status
OTC

Key Takeaways

  • NiQuitin Tropisk Frukt is a nicotine replacement therapy chewing gum with a tropical fruit flavor, available in 2 mg (for lighter smokers) and 4 mg (for heavier smokers) strengths to help people quit smoking.
  • Nicotine replacement therapy approximately doubles the chances of successfully quitting smoking compared to placebo, according to Cochrane systematic reviews of over 130 clinical trials.
  • The gum should be chewed using the "chew and park" technique: chew slowly until a tingling taste appears, then park between cheek and gum to allow buccal absorption. Each piece lasts approximately 30 minutes.
  • A standard treatment course lasts 12 weeks with gradual dose reduction: 8–12 pieces daily for weeks 1–6, then tapering over weeks 7–12 before discontinuation.
  • Common side effects include hiccups, mouth irritation, jaw ache, and nausea, which typically improve with correct chewing technique. The gum is available without a prescription and can be combined with other NRT forms for enhanced efficacy.

What Is NiQuitin Tropisk Frukt and What Is It Used For?

Quick Answer: NiQuitin Tropisk Frukt is a medicated nicotine chewing gum with a tropical fruit flavor, used as a nicotine replacement therapy to help smokers quit. It delivers nicotine through the oral mucosa to reduce cravings and withdrawal symptoms associated with stopping smoking, without exposing the user to the tar, carbon monoxide, and thousands of other harmful chemicals found in cigarette smoke.

NiQuitin Tropisk Frukt belongs to the class of medications known as nicotine replacement therapies (NRTs). The active ingredient is nicotine, delivered in the form of nicotine polacrilex (a nicotine-resin complex) embedded within a specially formulated chewing gum base. When the gum is chewed, nicotine is gradually released from the resin complex and absorbed through the buccal mucosa (the lining of the mouth), providing a controlled dose of nicotine to the bloodstream. The tropical fruit flavor is designed to make the experience of using the gum more palatable, which can improve adherence to the cessation program.

Tobacco smoking remains the leading preventable cause of death worldwide, responsible for more than 8 million deaths annually according to the World Health Organization (WHO). Cigarette smoke contains over 7,000 chemicals, of which at least 70 are known carcinogens. While nicotine itself is the primary addictive component in tobacco, it is not the principal cause of smoking-related diseases. Rather, it is the tar, carbon monoxide, hydrogen cyanide, heavy metals, and other toxic combustion byproducts that cause cancer, cardiovascular disease, chronic obstructive pulmonary disease (COPD), and a host of other serious conditions. Nicotine replacement therapy exploits this distinction by providing nicotine in a much cleaner form, allowing the smoker to address their chemical addiction while eliminating exposure to the most harmful components of tobacco smoke.

The pharmacological basis of NRT is well established. Nicotine exerts its addictive effects primarily by binding to nicotinic acetylcholine receptors (nAChRs) in the mesolimbic dopamine system of the brain, particularly the alpha-4 beta-2 subtype. When a smoker inhales cigarette smoke, nicotine reaches the brain within approximately 10 to 20 seconds, producing a rapid surge in dopamine release in the nucleus accumbens that reinforces the smoking behavior. With repeated use, the brain upregulates the number of nAChRs, leading to tolerance and physical dependence. When nicotine levels fall, the unoccupied receptors trigger a constellation of withdrawal symptoms including irritability, anxiety, difficulty concentrating, restlessness, increased appetite, depressed mood, and intense cravings for cigarettes.

NiQuitin Tropisk Frukt addresses these withdrawal symptoms by providing a slower, more controlled delivery of nicotine compared to cigarettes. While a cigarette delivers a bolus of nicotine to the brain in seconds, nicotine gum produces a more gradual rise in plasma nicotine levels, with peak concentrations reached approximately 20 to 30 minutes after chewing begins. This slower absorption profile partially satisfies the nAChRs, reducing withdrawal symptoms and cravings, but does not produce the rapid "spike" that reinforces the addictive cycle. Over time, by gradually reducing the number of gum pieces used per day, the user can progressively lower their nicotine intake until they are completely free from nicotine dependence.

The evidence supporting NRT for smoking cessation is robust and comprehensive. The most recent Cochrane systematic review (2023), which analyzed data from over 130 randomized controlled trials involving more than 64,000 participants, concluded that all forms of NRT (gum, patches, lozenges, inhalers, and nasal sprays) increase the rate of successful long-term smoking cessation by 50 to 60% compared to placebo. In absolute terms, NRT helps approximately an additional 5 to 7 out of every 100 smokers to quit successfully. When nicotine gum is used in combination with a nicotine patch (so-called "combination NRT"), quit rates can be further improved, approaching those seen with prescription medications such as varenicline.

Why Nicotine Replacement Therapy Works

NRT works by providing a controlled, lower dose of nicotine to partially activate brain receptors and reduce withdrawal symptoms without the harmful chemicals in tobacco smoke. The gradual delivery and progressive dose reduction help break both the chemical dependence on nicotine and the behavioral habits associated with smoking. Combining NRT with behavioral support (counseling, quit lines, or digital programs) further increases quit rates by 10 to 25%.

What Should You Know Before Taking NiQuitin Tropisk Frukt?

Quick Answer: Do not use NiQuitin Tropisk Frukt if you are a non-smoker, are under 18, or have a known allergy to nicotine or any ingredient in the gum. Consult your doctor before using if you have cardiovascular disease, diabetes, kidney or liver disease, stomach ulcers, or thyroid disorders. Pregnant and breastfeeding women should try to quit without NRT first, but may use it under medical supervision if necessary.

Contraindications

NiQuitin Tropisk Frukt should not be used by individuals who have a known hypersensitivity (allergy) to nicotine or any of the other ingredients in the gum formulation, including flavoring agents, sweeteners, or gum base components. The product is intended only for current smokers who wish to quit; non-smokers and occasional tobacco users should not use nicotine replacement therapy. Children under 12 years of age should not use nicotine gum, and for adolescents aged 12 to 17, use should only occur under the supervision of a healthcare professional.

Patients with certain medical conditions require special consideration before starting NRT. While NRT is generally considered much safer than continued smoking for patients with cardiovascular disease, those who have experienced a recent myocardial infarction (within the past 4 weeks), unstable or worsening angina pectoris, Prinzmetal's angina (vasospastic angina), serious cardiac arrhythmias, or recent cerebrovascular accident (stroke) should consult their physician before using nicotine gum. In these situations, the potential risks and benefits must be carefully weighed, though it should be noted that the cardiovascular risk of continued smoking almost always exceeds the risk of NRT.

Warnings and Precautions

Before starting NiQuitin Tropisk Frukt, discuss the following conditions with your healthcare provider:

  • Cardiovascular disease: Nicotine can increase heart rate and blood pressure. While NRT delivers lower and more stable nicotine levels than cigarettes, patients with severe cardiovascular conditions should use it under medical guidance. The benefits of smoking cessation through NRT typically far outweigh the risks.
  • Diabetes mellitus: Smoking cessation itself (with or without NRT) can affect blood glucose levels. Smokers with diabetes may need to adjust their insulin or oral hypoglycemic medication doses when they quit. Monitor blood glucose closely during cessation.
  • Peptic ulcer disease and gastritis: Nicotine can increase gastric acid secretion. If swallowed rather than absorbed buccally, the gum may worsen gastrointestinal symptoms. Correct chewing technique is especially important in these patients.
  • Hyperthyroidism and pheochromocytoma: Nicotine stimulates the release of catecholamines from the adrenal medulla. Patients with uncontrolled hyperthyroidism or pheochromocytoma should use nicotine products with caution.
  • Renal and hepatic impairment: Nicotine is primarily metabolized in the liver and its metabolites are excreted by the kidneys. Patients with severe liver or kidney disease may have altered nicotine metabolism, potentially leading to higher plasma levels.
  • Dental conditions: The chewing gum may adhere to and potentially damage dental work including dentures, bridges, crowns, and braces. Patients with temporomandibular joint (TMJ) disorders may also experience worsened jaw pain from the repetitive chewing motion.

Pregnancy and Breastfeeding

Smoking during pregnancy is associated with numerous adverse outcomes including miscarriage, stillbirth, premature birth, low birth weight, placental abruption, and sudden infant death syndrome (SIDS). Ideally, pregnant women should quit smoking without the use of any nicotine-containing products. However, if a pregnant woman has been unable to quit through behavioral interventions alone, nicotine replacement therapy may be considered as a pharmacological aid, as the health risks of continued smoking generally exceed those of NRT.

When NRT is used during pregnancy, intermittent-dose formulations such as nicotine gum are generally preferred over continuous-delivery forms such as the nicotine patch, because they deliver a lower total daily dose of nicotine and can be used only when cravings are strongest. However, any use of NRT during pregnancy should be under the guidance and supervision of a healthcare professional. The 2 mg strength is recommended to minimize fetal nicotine exposure. Treatment should be as short as possible, and the patient should be re-evaluated if she is still using NRT after 2 to 3 months.

Nicotine passes into breast milk in quantities proportional to the maternal plasma concentration. While NRT exposes the infant to nicotine through breast milk, the exposure is lower than that from secondhand smoke generated by a mother who continues to smoke. If NRT is used while breastfeeding, the gum should be chewed and discarded at least 30 minutes before nursing to minimize the infant's nicotine exposure via breast milk.

Driving and Operating Machinery

NiQuitin Tropisk Frukt is not known to impair the ability to drive or use machines. However, it should be noted that smoking cessation itself can cause temporary changes in concentration and mood due to nicotine withdrawal. These effects are generally mild and typically resolve within the first few weeks of quitting. If you experience dizziness, difficulty concentrating, or any other symptoms that could affect your ability to drive safely, wait until these symptoms resolve before driving or operating heavy machinery.

How Does NiQuitin Tropisk Frukt Interact with Other Drugs?

Quick Answer: NiQuitin Tropisk Frukt itself has few direct drug interactions. However, the act of quitting smoking can significantly alter the metabolism of many medications because tobacco smoke (not nicotine) induces certain liver enzymes. Drugs metabolized by CYP1A2, such as theophylline, clozapine, olanzapine, and caffeine, may require dose adjustments when smoking is stopped.

Understanding drug interactions with nicotine replacement therapy requires distinguishing between two separate pharmacological phenomena: interactions caused by nicotine itself, and interactions caused by the cessation of tobacco smoke. This distinction is critical because many of the most clinically significant "interactions" attributed to NRT are actually the result of changes in drug metabolism that occur when a patient stops smoking, regardless of whether they use NRT.

Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs) that are potent inducers of the hepatic cytochrome P450 enzyme CYP1A2. When a patient smokes, CYP1A2 activity is significantly upregulated, leading to faster metabolism of drugs that are substrates of this enzyme. When the patient stops smoking, CYP1A2 activity returns to baseline levels over a period of approximately 3 to 7 days, resulting in slower metabolism and potentially higher plasma concentrations of these drugs. This effect occurs regardless of whether NRT is used, because it is the PAHs in smoke (not nicotine) that induce CYP1A2.

Nicotine itself has relatively few direct pharmacokinetic interactions. However, nicotine does have pharmacodynamic effects (such as increasing heart rate and blood pressure through sympathetic nervous system stimulation) that may interact with certain medications.

Important Drug Interactions When Quitting Smoking
Drug Mechanism Clinical Significance
Theophylline CYP1A2 substrate; levels increase when smoking stops Major – dose reduction may be needed; monitor levels
Clozapine CYP1A2 substrate; levels can increase 50–70% Major – dose reduction essential; monitor closely
Olanzapine CYP1A2 substrate; metabolism slows after cessation Moderate – may need dose adjustment
Warfarin CYP1A2 partially involved; INR may increase Moderate – monitor INR more frequently
Insulin Smoking increases insulin resistance; cessation improves sensitivity Moderate – may need to reduce insulin dose
Caffeine CYP1A2 substrate; levels may increase significantly Minor – consider reducing caffeine intake
Fluvoxamine CYP1A2 substrate; plasma levels may rise Moderate – monitor for side effects
Ropinirole CYP1A2 substrate; clearance decreases Moderate – may need dose adjustment

Major Interactions

The most clinically important interactions to be aware of when quitting smoking with NiQuitin involve medications with narrow therapeutic indices that are metabolized by CYP1A2. Theophylline is the classic example: smoking increases theophylline clearance by 50 to 100%, so when a patient stops smoking, theophylline levels can rise dramatically, potentially reaching toxic concentrations. Symptoms of theophylline toxicity include nausea, vomiting, tachycardia, seizures, and cardiac arrhythmias. Patients taking theophylline should have their blood levels monitored closely during smoking cessation, with dose reductions of 25 to 50% typically required.

Clozapine represents another critical interaction. Smoking induces CYP1A2, which is a major pathway for clozapine metabolism. When a patient on clozapine stops smoking, plasma clozapine levels can increase by 50 to 70%, potentially leading to serious adverse effects including excessive sedation, seizures, metabolic disturbances, and potentially life-threatening agranulocytosis at higher concentrations. Clozapine doses should be proactively reduced by approximately 25 to 50% when a patient stops smoking, with frequent monitoring of plasma clozapine levels.

Minor Interactions

Caffeine is metabolized almost entirely by CYP1A2, and smokers metabolize caffeine approximately 50% faster than non-smokers. When smoking stops, caffeine metabolism slows, potentially leading to higher caffeine levels and symptoms such as insomnia, anxiety, restlessness, and palpitations. Patients experiencing these symptoms after quitting should be advised to reduce their caffeine intake by approximately half. Acidic beverages (coffee, fruit juice, carbonated drinks) consumed within 15 minutes of using nicotine gum can reduce the pH of the oral cavity and significantly decrease nicotine absorption through the buccal mucosa. Patients should avoid these beverages immediately before and during gum use.

What Is the Correct Dosage of NiQuitin Tropisk Frukt?

Quick Answer: Use the 2 mg gum if you smoke your first cigarette more than 30 minutes after waking, or the 4 mg gum if you smoke within 30 minutes of waking. Chew 8 to 12 pieces per day during weeks 1–6, reduce to one piece every 2–4 hours in weeks 7–9, and taper to one piece every 4–8 hours in weeks 10–12. Do not exceed 15 pieces per day (4 mg) or 24 pieces per day (2 mg).

Choosing the Right Strength

The correct strength of NiQuitin Tropisk Frukt depends on your level of nicotine dependence. The simplest and most widely validated method for estimating nicotine dependence is the time to first cigarette (TTFC) after waking, which is derived from the Fagerström Test for Nicotine Dependence (FTND). This single question is a powerful predictor of the intensity of nicotine dependence and the appropriate NRT dose:

  • 2 mg strength: Recommended if you smoke your first cigarette more than 30 minutes after waking. This suggests a moderate level of nicotine dependence.
  • 4 mg strength: Recommended if you smoke your first cigarette within 30 minutes of waking. This indicates higher nicotine dependence and a need for more aggressive replacement.

Research consistently demonstrates that matching the NRT dose to the level of dependence improves quit rates. A pivotal meta-analysis found that the 4 mg gum was significantly more effective than the 2 mg gum for highly dependent smokers (those smoking 25 or more cigarettes per day or with high FTND scores), whereas the 2 mg gum was equally effective for less dependent smokers.

Adults (18 Years and Over)

Recommended Dosage Schedule for Adults
Phase Weeks Frequency Pieces Per Day
Phase 1 (Full dose) Weeks 1–6 1 piece every 1–2 hours 8–12 pieces
Phase 2 (Taper) Weeks 7–9 1 piece every 2–4 hours 4–8 pieces
Phase 3 (Weaning) Weeks 10–12 1 piece every 4–8 hours 2–4 pieces

The maximum recommended daily intake is 15 pieces for the 4 mg gum and 24 pieces for the 2 mg gum. Do not exceed these limits. The total recommended treatment duration is 12 weeks. Some smokers may benefit from a longer treatment course, but use beyond 6 months should be discussed with a healthcare professional. There is evidence that extended NRT use (beyond the standard 12 weeks) can further improve long-term quit rates in some populations.

Correct Chewing Technique

Proper chewing technique is essential for effective nicotine delivery and to minimize side effects. Many side effects associated with nicotine gum (such as hiccups, nausea, heartburn, and jaw soreness) result from incorrect chewing technique rather than from nicotine itself. The recommended "chew and park" method is as follows:

  1. Chew slowly until you notice a peppery, tingling, or distinctive taste (usually after about 15 chews). This indicates that nicotine is being released from the resin complex.
  2. Park the gum between your cheek and gum (buccal mucosa). This position allows nicotine to be absorbed directly through the oral lining into the bloodstream.
  3. Wait until the tingling or taste fades (approximately 1 to 2 minutes), then chew again slowly a few more times.
  4. Repeat the chew-and-park cycle for approximately 30 minutes per piece of gum.
  5. Do not chew continuously like regular gum, as this causes nicotine to be released too quickly, leading to swallowing of nicotine rather than buccal absorption. Swallowed nicotine is largely inactivated by first-pass metabolism in the liver and causes gastrointestinal side effects.

Avoid eating or drinking (especially acidic beverages such as coffee, fruit juice, or soft drinks) for 15 minutes before and during gum use, as an acidic oral environment significantly reduces nicotine absorption through the buccal mucosa.

Children and Adolescents

NiQuitin Tropisk Frukt is not recommended for use in children under 12 years of age. Adolescents aged 12 to 17 who wish to use nicotine gum for smoking cessation should do so only under the supervision of a healthcare professional. The dosing is the same as for adults, but the duration of treatment should generally be shorter, and regular monitoring is advisable.

Elderly

No specific dose adjustments are necessary for elderly patients. However, older adults may have reduced renal or hepatic function that could alter nicotine metabolism. Elderly patients are also more likely to have cardiovascular comorbidities that warrant medical supervision during NRT use. Standard dosing recommendations apply, but healthcare providers should be aware of the potential for altered pharmacokinetics.

Missed Dose

Because NiQuitin Tropisk Frukt is used on an as-needed basis to manage cravings, there is no strict concept of a "missed dose" as with fixed-schedule medications. If you forget to use a piece of gum at your usual time, simply use the next piece when you feel the next craving. Do not double up by chewing two pieces simultaneously to make up for missed use. The goal is to maintain a relatively stable level of nicotine throughout the day to prevent withdrawal symptoms and cravings from becoming overwhelming.

Overdose

The risk of nicotine overdose from the gum alone is relatively low in adult smokers because the nausea that accompanies early signs of excessive nicotine intake typically limits further consumption. Additionally, the gradual absorption from the gum is much less likely to produce acutely toxic levels compared to ingestion of liquid nicotine products. However, the risk increases substantially when multiple nicotine-containing products are used simultaneously without appropriate dose adjustment, or if gum pieces are accidentally ingested by children.

What Are the Side Effects of NiQuitin Tropisk Frukt?

Quick Answer: The most common side effects of NiQuitin Tropisk Frukt include hiccups, mouth and throat irritation, jaw ache, nausea, and headache. Most side effects are mild and diminish with continued use and proper chewing technique. Serious adverse effects are uncommon. Many symptoms experienced during NRT may actually be nicotine withdrawal symptoms rather than side effects of the gum itself.

Like all medicines, NiQuitin Tropisk Frukt can cause side effects, although not everybody gets them. It is important to distinguish between genuine side effects of the nicotine gum and symptoms of nicotine withdrawal, which occur as part of the normal process of quitting smoking. Withdrawal symptoms such as irritability, anxiety, difficulty concentrating, increased appetite, depressed mood, and sleep disturbance are expected during smoking cessation and are not caused by the gum itself. In fact, one of the primary purposes of the gum is to reduce these withdrawal symptoms.

Many of the local side effects associated with nicotine gum (mouth irritation, hiccups, nausea, heartburn) are related to the chewing technique rather than to nicotine per se. Vigorous or continuous chewing releases nicotine too quickly, causing it to be swallowed rather than absorbed through the buccal mucosa. This leads to gastrointestinal irritation and reduced therapeutic efficacy. Proper "chew and park" technique can substantially reduce these effects.

Very Common

May affect more than 1 in 10 people

  • Hiccups
  • Mouth and throat irritation or soreness
  • Nausea
  • Jaw muscle ache (from chewing)
  • Headache

Common

May affect up to 1 in 10 people

  • Dizziness or lightheadedness
  • Gastrointestinal discomfort (heartburn, indigestion, flatulence)
  • Increased salivation
  • Taste disturbance or unpleasant taste
  • Oral mucosal ulceration (mouth sores)
  • Insomnia or sleep disturbance
  • Palpitations

Uncommon

May affect up to 1 in 100 people

  • Skin rash or urticaria (hives)
  • Flushing
  • Chest discomfort
  • Increased blood pressure
  • Dry mouth
  • Numbness or tingling in the mouth

Rare

May affect up to 1 in 1,000 people

  • Allergic reactions (angioedema, anaphylaxis)
  • Cardiac arrhythmias (irregular heartbeat)
  • Dysphagia (difficulty swallowing)
  • Severe gum or dental damage

If any side effect becomes severe or troublesome, or if you notice any side effect not listed above, please consult your healthcare provider or pharmacist. In most cases, adjusting the chewing technique or reducing the number of gum pieces used per day will resolve the issue. If you experience symptoms suggestive of nicotine toxicity (severe nausea, vomiting, tremor, rapid heartbeat, cold sweats), stop using the gum and seek medical advice.

It is worth noting that some side effects, particularly oral and dental effects, may be more pronounced in patients who use nicotine gum over extended periods. Long-term gum users should maintain regular dental check-ups and report any persistent oral symptoms to their dentist or healthcare provider.

How Should You Store NiQuitin Tropisk Frukt?

Quick Answer: Store NiQuitin Tropisk Frukt at room temperature below 25°C (77°F) in the original packaging, protected from light and moisture. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging. Dispose of used gum pieces safely by wrapping them in paper and discarding in household waste.

NiQuitin Tropisk Frukt should be stored at room temperature, ideally below 25°C (77°F). Do not freeze the gum. Keep the product in its original blister packaging until use, as this protects the medicated gum from moisture and light, which can degrade the nicotine and alter the product's effectiveness. The blister pack also provides a tamper-evident barrier that helps ensure product integrity.

The gum should be kept well out of reach and sight of children at all times. This applies to both unused and used gum pieces. Even after 30 minutes of use, a piece of nicotine gum may retain a significant amount of residual nicotine that could be harmful if chewed or swallowed by a child. Used gum should be wrapped in paper or placed back in the blister pocket and disposed of in the household waste. Do not discard nicotine gum in a way that allows access by children or pets.

Do not use the product after the expiry date (EXP) printed on the outer packaging and individual blister strips. The expiry date refers to the last day of that month. Expired nicotine products may have reduced potency due to degradation of the active ingredient and should be disposed of according to local pharmaceutical waste guidelines. Ask your pharmacist how to dispose of medicines you no longer use. Do not flush nicotine products down the toilet or throw them into the environment.

What Does NiQuitin Tropisk Frukt Contain?

Quick Answer: The active ingredient is nicotine (as nicotine polacrilex/nicotine-resin complex), available in 2 mg and 4 mg strengths per piece of gum. The gum base also contains flavoring agents (tropical fruit flavor), sweeteners, and other excipients that provide the product's taste, texture, and stability.

Each piece of NiQuitin Tropisk Frukt medicated chewing gum contains the following:

Active ingredient: Nicotine, delivered as nicotine polacrilex (a nicotine bound to an ion-exchange resin complex). The two available strengths are:

  • 2 mg: Each piece of gum contains 2 mg of nicotine (as nicotine polacrilex), equivalent to approximately 10 mg of nicotine polacrilex resin complex.
  • 4 mg: Each piece of gum contains 4 mg of nicotine (as nicotine polacrilex), equivalent to approximately 20 mg of nicotine polacrilex resin complex.

Other ingredients (excipients): The gum base typically contains a chewing gum base (consisting of various food-grade polymers and waxes), flavoring agents providing the tropical fruit taste, sweeteners such as xylitol and acesulfame potassium (to provide sweetness without contributing to dental caries), sodium carbonate (an alkalizing agent that raises the oral pH to facilitate nicotine absorption through the buccal mucosa), glycerol, and various other standard pharmaceutical excipients for texture and stability.

The tropical fruit flavoring is added to improve palatability and mask the naturally bitter taste of nicotine, which can be off-putting to some users and may reduce adherence to the cessation program. Studies have shown that flavored nicotine gums can improve compliance with treatment regimens compared to unflavored versions, particularly among users who find the taste of plain or mint-flavored nicotine gum unpleasant.

The sodium carbonate (or sodium bicarbonate) in the formulation serves an important pharmacological function beyond flavoring. By raising the pH of saliva in the mouth to a mildly alkaline level, it promotes the conversion of nicotine from its ionized (protonated) form to its non-ionized (free base) form. The non-ionized form of nicotine is much more readily absorbed across the buccal mucosa, significantly improving the bioavailability of the product. This is why acidic beverages should be avoided before and during gum use, as they can neutralize this pH-raising effect and reduce nicotine absorption.

Frequently Asked Questions

NiQuitin Tropisk Frukt is a tropical fruit flavored nicotine chewing gum used as a nicotine replacement therapy (NRT) to help people stop smoking. It provides a controlled dose of nicotine through the lining of the mouth to reduce withdrawal symptoms and cravings associated with quitting tobacco. It is available in 2 mg and 4 mg strengths and can be purchased without a prescription in most countries.

Chew the gum slowly until you notice a peppery or tingling taste, then park (rest) the gum between your cheek and gum to allow nicotine absorption through the oral mucosa. When the taste fades, chew again briefly and repeat the chew-and-park cycle. Each piece should be chewed for about 30 minutes. Do not eat or drink (especially acidic beverages) for 15 minutes before or during use, as this can reduce nicotine absorption.

The most common side effects include hiccups, mouth and throat irritation, jaw ache from chewing, nausea, and headache. These effects are usually mild and tend to decrease with continued use as proper chewing technique is mastered. Gastrointestinal symptoms such as indigestion or heartburn may occur if the gum is chewed too vigorously, causing nicotine to be swallowed rather than absorbed through the mouth.

Ideally, smoking cessation during pregnancy should be achieved without nicotine replacement therapy. However, if a pregnant woman is unable to quit without pharmacological support, NRT may be considered under medical supervision as it is generally considered less harmful than continued smoking. Nicotine in any form can affect fetal development, so a healthcare provider should weigh the risks and benefits. Intermittent-use forms like gum may be preferred over patches during pregnancy as they deliver lower total daily nicotine doses.

A typical course of nicotine gum treatment lasts 12 weeks. During the first 6 weeks, use a piece of gum every 1–2 hours (usually 8–12 pieces per day). During weeks 7–9, gradually reduce to one piece every 2–4 hours. During weeks 10–12, reduce further to one piece every 4–8 hours. After 12 weeks, discontinue use. Some individuals may need a longer course. Do not use nicotine gum for longer than 6 months without consulting a healthcare professional.

The 2 mg strength is recommended for smokers who smoke their first cigarette more than 30 minutes after waking (lower nicotine dependence). The 4 mg strength is recommended for smokers who smoke their first cigarette within 30 minutes of waking (higher nicotine dependence). Choosing the correct strength based on your level of dependence improves the chances of successfully quitting smoking.

References

  1. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2018;(5):CD000146. Updated 2023.
  2. World Health Organization. WHO Report on the Global Tobacco Epidemic 2023. Geneva: WHO; 2023.
  3. National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline [NG209]. 2023.
  4. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2019;(4):CD013308.
  5. European Medicines Agency. NiQuitin Summary of Product Characteristics. EMA; 2024.
  6. Benowitz NL. Nicotine addiction. New England Journal of Medicine. 2010;362(24):2295-2303.
  7. U.S. Food and Drug Administration. OTC Nicotine Replacement Therapy: Safety and Efficacy Information. FDA; 2024.
  8. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; 2008.
  9. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2012;(11):CD000146.
  10. European Respiratory Society / European Network for Smoking and Tobacco Prevention. Joint Statement: Smoking Cessation in Patients with Respiratory Diseases. ERS/ENSP; 2023.

Editorial Team

Medical Content

iMedic Medical Editorial Team – Specialists in Addiction Medicine and Clinical Pharmacology

Medical Review

iMedic Medical Review Board – Independent panel reviewing content according to WHO, EMA, and FDA guidelines

Evidence Standard

Level 1A – Based on systematic reviews and meta-analyses of randomized controlled trials (GRADE framework)

Accessibility

WCAG 2.2 Level AAA – Fully accessible for screen readers, keyboard navigation, and assistive technology

All content is independently produced with no commercial funding or pharmaceutical sponsorship. Last medical review: .